ARCTURUS THERAPEUTICS HOLDINGS INC. Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) reported Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent of 0.20% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther · last filed 2022-03-01
- ARCTURUS THERAPEUTICS HOLDINGS INC. effective income tax rate reconciliation, tax credit, other, percent for fiscal 2021 was 0.20%.
- ARCTURUS THERAPEUTICS HOLDINGS INC. effective income tax rate reconciliation, tax credit, other, percent for fiscal 2020 was -0.10%, a 200.00% decline from fiscal 2019.
- ARCTURUS THERAPEUTICS HOLDINGS INC. effective income tax rate reconciliation, tax credit, other, percent for fiscal 2019 was 0.10%.
- ARCTURUS THERAPEUTICS HOLDINGS INC. effective income tax rate reconciliation, tax credit, other, percent for fiscal 2018 was -3.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent 12 month |
|---|---|
| 2021-12-31 | 0.20% 10-K · filed 2022-03-01 |
| 2020-12-31 | -0.10% 10-K · filed 2022-03-01 |
| 2019-12-31 | 0.10% 10-K · filed 2022-03-01 |
| 2018-12-31 | -3.00% 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |